|
|
Previous Article | Table of Contents | Next Article 
Selection of retrovirally transduced hematopoietic cells using CD24 as a
marker of gene transfer
R Pawliuk, R Kay, P Lansdorp and RK Humphries
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada.
We have investigated the use of a cell surface antigen as a dominant
selectable marker to facilitate the detection and selection of retrovirally
infected target cells. The small coding region of the human cell surface
antigen CD24 (approximately 240 bp) was introduced into a
myeloproliferative sarcoma virus (MPSV)-based retroviral vector, which was
then used to infect day 4 5-fluorouracil (5-FU)-treated murine bone marrow
cells. Within 48 hours of termination of the infection procedure
CD24-expressing cells were selected by fluorescent- activated cell sorting
(FACS) with an antibody directed against the CD24 antigen. Functional
analysis of these cells showed that they included not only in vitro
clonogenic progenitors and day 12 colony- forming unit-spleen but also
cells capable of competitive long-term hematopoietic repopulation.
Double-antibody labeling studies performed on recipients of retrovirally
transduced marrow cells showed that some granulocytes, macrophages,
erythrocytes, and, to a lesser extent, B and T lymphocytes still expressed
the transduced CD24 gene at high levels 4 months later. No gross
abnormalities in hematopoiesis were detected in mice repopulated with
CD24-expressing cells. Our results show that the use of the CD24 cell
surface antigen as a retrovirally encoded marker enables the rapid,
efficient, and nontoxic selection in vitro of infected primary cells,
facilitates tracking and phenotyping of their progeny, and should provide a
unique tool to identify elements that regulate the expression of transduced
genes in the most primitive hematopoietic cells.
Volume 84,
Issue 9,
pp. 2868-2877,
11/01/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Pineault, C. Buske, M. Feuring-Buske, C. Abramovich, P. Rosten, D. E. Hogge, P. D. Aplan, and R. K. Humphries
Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1
Blood,
June 1, 2003;
101(11):
4529 - 4538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Imren, E. Payen, K. A. Westerman, R. Pawliuk, M. E. Fabry, C. J. Eaves, B. Cavilla, L. D. Wadsworth, Y. Beuzard, E. E. Bouhassira, et al.
Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells
PNAS,
October 29, 2002;
99(22):
14380 - 14385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Thorsteinsdottir, A. Mamo, E. Kroon, L. Jerome, J. Bijl, H. J. Lawrence, K. Humphries, and G. Sauvageau
Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion
Blood,
January 1, 2002;
99(1):
121 - 129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Qin, T. Takenaka, K. Telsch, L. Kelley, T. Howard, T. Levade, R. Deans, B. H. Howard, H. L. Malech, R. O. Brady, et al.
Preselective gene therapy for Fabry disease
PNAS,
March 1, 2001;
(2001)
61020598.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. A. Klug, S. Cheshier, and I. L. Weissman
Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny
Blood,
August 1, 2000;
96(3):
894 - 901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rosenzweig, T.J. MacVittie, D. Harper, D. Hempel, R.L. Glickman, R.P. Johnson, A.M. Farese, N. Whiting-Theobald, G.F. Linton, G. Yamasaki, et al.
Efficient and Durable Gene Marking of Hematopoietic Progenitor Cells in Nonhuman Primates After Nonablative Conditioning
Blood,
October 1, 1999;
94(7):
2271 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kume, M. Hashiyama, T. Suda, and K. Ozawa
Green Fluorescent Protein as a Selectable Marker of Retrovirally Transduced Hematopoietic Progenitors
Stem Cells,
July 1, 1999;
17(4):
226 - 232.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Erlich, S. R.P. Miranda, J. W.M. Visser, A. Dagan, S. Gatt, and E. H. Schuchman
Fluorescence-Based Selection of Gene-Corrected Hematopoietic Stem and Progenitor Cells From Acid Sphingomyelinase-Deficient Mice: Implications for Niemann-Pick Disease Gene Therapy and the Development of Improved Stem Cell Gene Transfer Procedures
Blood,
January 1, 1999;
93(1):
80 - 86.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Pear, J. P. Miller, L. Xu, J. C. Pui, B. Soffer, R. C. Quackenbush, A. M. Pendergast, R. Bronson, J. C. Aster, M. L. Scott, et al.
Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow
Blood,
November 15, 1998;
92(10):
3780 - 3792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.F. Tisdale, Y. Hanazono, S.E. Sellers, B.A. Agricola, M.E. Metzger, R.E. Donahue, and C.E. Dunbar
Ex Vivo Expansion of Genetically Marked Rhesus Peripheral Blood Progenitor Cells Results in Diminished Long-Term Repopulating Ability
Blood,
August 15, 1998;
92(4):
1131 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Onodera, D. M. Nelson, A. Yachie, G. J. Jagadeesh, B. A. Bunnell, R. A. Morgan, and R. M. Blaese
Development of Improved Adenosine Deaminase Retroviral Vectors
J. Virol.,
March 1, 1998;
72(3):
1769 - 1774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Garcia-Hernandez, A. Castellanos, A. Lopez, A. Orfao, and I. Sanchez-Garcia
Murine hematopoietic reconstitution after tagging and selection of retrovirally transduced bone marrow cells
PNAS,
November 25, 1997;
94(24):
13239 - 13244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ito, Y. Ueda, M. Kokubun, M. Urabe, T. Inaba, H. Mano, H. Hamada, T. Kitamura, H. Mizoguchi, T. Sakata, et al.
Development of a Novel Selective Amplifier Gene for Controllable Expansion of Transduced Hematopoietic Cells
Blood,
November 15, 1997;
90(10):
3884 - 3892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F.A. Bierhuizen, Y. Westerman, T. P. Visser, W. Dimjati, A. W. Wognum, and G. Wagemaker
Enhanced Green Fluorescent Protein as Selectable Marker of Retroviral-Mediated Gene Transfer in Immature Hematopoietic Bone Marrow Cells
Blood,
November 1, 1997;
90(9):
3304 - 3315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Raftopoulos, M. Ward, P. Leboulch, and A. Bank
Long-Term Transfer and Expression of the Human beta -Globin Gene in a Mouse Transplant Model
Blood,
November 1, 1997;
90(9):
3414 - 3422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Persons, J. A. Allay, E. R. Allay, R. J. Smeyne, R. A. Ashmun, B. P. Sorrentino, and A. W. Nienhuis
Retroviral-Mediated Transfer of the Green Fluorescent Protein Gene Into Murine Hematopoietic Cells Facilitates Scoring and Selection of Transduced Progenitors In Vitro and Identification of Genetically Modified Cells In Vivo
Blood,
September 1, 1997;
90(5):
1777 - 1786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mardiney III, S. H. Jackson, S. K. Spratt, F. Li, S. M. Holland, and H. L. Malech
Enhanced Host Defense After Gene Transfer in the Murine p47phox-Deficient Model of Chronic Granulomatous Disease
Blood,
April 1, 1997;
89(7):
2268 - 2275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Sauvageau, U Thorsteinsdottir, C J Eaves, H J Lawrence, C Largman, P M Lansdorp, and R K Humphries
Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo.
Genes & Dev.,
July 15, 1995;
9(14):
1753 - 1765.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Qin, T. Takenaka, K. Telsch, L. Kelley, T. Howard, T. Levade, R. Deans, B. H. Howard, H. L. Malech, R. O. Brady, et al.
Preselective gene therapy for Fabry disease
PNAS,
March 13, 2001;
98(6):
3428 - 3433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Kalberer, R. Pawliuk, S. Imren, T. Bachelot, K. J. Takekoshi, M. Fabry, C. J. Eaves, I. M. London, R. K. Humphries, and P. Leboulch
From the Cover: Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta -globin in engrafted mice
PNAS,
May 9, 2000;
97(10):
5411 - 5415.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|